Instil Bio, Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-4.3M | $-4.2M | $-8.2M | $-13.6M | $-21.4M | $-28.2M | $-11.9M | $-23.0M |
| Depreciation & Amortization | $248.0K | $12.0K | $12.0K | $12.0K | $12.0K | $498.0K | $741.0K | $901.0K |
| Depreciation | $200.0K | $0 | $-10.0K | $10.0K | $0 | $500.0K | $700.0K | $900.0K |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $1.0M | $985.0K | $1.6M | $1.8M | $1.8M | $3.5M | $4.5M | $4.1M |
| Net Cash from Operating Activities | $-4.6M | $-1.3M | $-7.1M | $-10.6M | $-14.8M | $-4.2M | $-10.6M | $-20.1M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | $0 | $0 |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $5.3M | $-317.0K | $7.8M | $8.4M | $-400.0K | $9.6M | $13.0M | $19.8M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $0 | $0 | $0 | $378.0K | $6.7M | $232.0K | $1.6M | $159.0K |
| Net Change in Cash | — | — | — | — | — | — | — | — |
| Free Cash Flow | — | — | — | — | — | — | $-10.6M | $-20.1M |